Liver transplantation for combined hepatocellular-cholangiocarcinoma: Outcomes and prognostic factors for mortality. A multicenter analysis.
Derar JaradatGeorgios BagiasThomas LorfYaman TokatAiman ObedArzu OezcelikPublished in: Clinical transplantation (2021)
Although overall survival rates are clearly decreased compared to HCC patients, liver transplantation should be taken under consideration for selected patients with early stage and real mixed HCC-CC, who are likely to benefit from liver transplantation.
Keyphrases
- prognostic factors
- early stage
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- peritoneal dialysis
- cardiovascular events
- cardiovascular disease
- clinical trial
- squamous cell carcinoma
- radiation therapy
- skeletal muscle
- coronary artery disease
- patient reported outcomes
- lymph node
- neoadjuvant chemotherapy
- weight loss
- sentinel lymph node